JV Fahy, DJ Figueroa, HH Wong, JT Liu and JS Abrams
Department of Medicine, University of California, San Francisco 94143, USA.

To determine if RANTES expression is unregulated in the airways of asthmatic subjects, we performed bronchial mucosal biopsies and airway lavage in seven atopic asthmatic subjects and eight healthy subjects. Immunohistochemistry was used to reveal RANTES protein expression in the airway biopsies. An ELISA was used to quantitate RANTES in lavage. In three subjects in each group, we also used in situ hybridization to reveal mRNA for RANTES in airway biopsies. We found that the mean (+/- SD) percent expression for RANTES in the epithelium and submucosa was 26 +/- 9% and 26 +/- 10% in the asthmatic and healthy tissue samples, respectively. RANTES mRNA was demonstrable in the bronchial mucosa of both healthy and asthmatic subjects, predominantly in the epithelial cells but also in the submucosa. We also found that there was no significant difference in the median RANTES concentrations between the groups (healthy: 2.9 pg/ml [range: 0.0 to 28.7 pg/ml]; asthma: 1.8 pg/ml [range: 0.0 to 82.1 pg/ml], p > 0.05) despite a trend for higher concentrations of eosinophil cationic protein (ECP) in the asthmatic group (p = 0.08). In summary, this study confirms that cells in airway mucosal tissue produce RANTES but that the level of production in mild stable asthma is not different from that of healthy control subjects.

This article has been cited by other articles:

				F. F. Little, E. Lynch, G. Fine, D. M. Center, and W. W. Cruikshank Tumor Necrosis Factor-{alpha}-Induced Synthesis of Interleukin-16 in Airway Epithelial Cells: Priming for Serotonin Stimulation Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 354 - 362. [Abstract] [Full Text] [PDF]

				M. J. Holtzman, J. D. Morton, L. P. Shornick, J. W. Tyner, M. P. O'Sullivan, A. Antao, M. Lo, M. Castro, and M. J. Walter Immunity, Inflammation, and Remodeling in the Airway Epithelial Barrier: Epithelial-Viral-Allergic Paradigm Physiol Rev, January 1, 2002; 82(1): 19 - 46. [Abstract] [Full Text] [PDF]

				F. F. Little, W. W. Cruikshank, and D. M. Center IL-9 Stimulates Release of Chemotactic Factors from Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 347 - 352. [Abstract] [Full Text] [PDF]

				Y. Niwa, H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki, and A. Abe Correlation of Tissue and Plasma RANTES Levels with Disease Course in Patients with Breast or Cervical Cancer Clin. Cancer Res., February 1, 2001; 7(2): 285 - 289. [Abstract] [Full Text]

				R. Hidi, V. Riches, M. Al-Ali, W. W. Cruikshank, D. M. Center, S. T. Holgate, and R. Djukanovic Role of B7-CD28/CTLA-4 Costimulation and NF-{kappa}B in Allergen-Induced T Cell Chemotaxis by IL-16 and RANTES J. Immunol., January 1, 2000; 164(1): 412 - 418. [Abstract] [Full Text] [PDF]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				P. Lacy, S. Mahmudi-Azer, B. Bablitz, S. C. Hagen, J. R. Velazquez, S.F. P. Man, and R. Moqbel Rapid Mobilization of Intracellularly Stored RANTES in Response to Interferon-gamma in Human Eosinophils Blood, July 1, 1999; 94(1): 23 - 32. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				M. Taguchi, D. Sampath, T. Koga, M. Castro, D. C. Look, S. Nakajima, and M. J. Holtzman Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo J. Exp. Med., June 15, 1998; 187(12): 1927 - 1940. [Abstract] [Full Text] [PDF]